Laurent Chiarelli

Laurent Chiarelli

Università degli Studi di Pavia

H-index: 35

Europe-Italy

About Laurent Chiarelli

Laurent Chiarelli, With an exceptional h-index of 35 and a recent h-index of 29 (since 2020), a distinguished researcher at Università degli Studi di Pavia, specializes in the field of Biochemistry, Medicinal Chemistry, Infectious Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus

Benzothiozinone derivatives with anti-tubercular Activity− Further side chain investigation

Iron acquisition and metabolism as a promising target for antimicrobials (bottlenecks and opportunities): where do we stand?

Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options

Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?

Targeting siderophore-mediated iron uptake in M. abscessus: a new strategy to limit the virulence of non-tuberculous mycobacteria

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

Laurent Chiarelli Information

University

Position

Department of Biology and Biotechnology

Citations(all)

4127

Citations(since 2020)

2354

Cited By

2604

hIndex(all)

35

hIndex(since 2020)

29

i10Index(all)

74

i10Index(since 2020)

62

Email

University Profile Page

Università degli Studi di Pavia

Google Scholar

View Google Scholar Profile

Laurent Chiarelli Skills & Research Interests

Biochemistry

Medicinal Chemistry

Infectious Diseases

Top articles of Laurent Chiarelli

Title

Journal

Author(s)

Publication Date

Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus

European Journal of Medicinal Chemistry

Matteo Mori

Mario Cocorullo

Andrea Tresoldi

Giulia Cazzaniga

Arianna Gelain

...

2024/2/5

Benzothiozinone derivatives with anti-tubercular Activity− Further side chain investigation

European Journal of Medicinal Chemistry

Xiaomei Wu

Wenxin Wang

Giovanni Stelitano

Olga Riabova

Bin Wang

...

2024/1/15

Iron acquisition and metabolism as a promising target for antimicrobials (bottlenecks and opportunities): where do we stand?

Giovanni Stelitano

Mario Cocorullo

Matteo Mori

Stefania Villa

Fiorella Meneghetti

...

2023/3/24

Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB

M Mori

G Cazzaniga

A Tresoldi

A Gelain

LR Chiarelli

...

2023/9/21

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options

Deborah Recchia

Giovanni Stelitano

Alessandro Stamilla

Damaris L Gutierrez

Giulia Degiacomi

...

2023/2/27

Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?

International Journal of Molecular Sciences

Maura D’Amato

Monica Campagnoli

Paolo Iadarola

Paola Margherita Bignami

Marco Fumagalli

...

2023/8/31

Targeting siderophore-mediated iron uptake in M. abscessus: a new strategy to limit the virulence of non-tuberculous mycobacteria

Pharmaceutics

Matteo Mori

Giovanni Stelitano

Giulia Cazzaniga

Arianna Gelain

Andrea Tresoldi

...

2023/2

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

Biomedicines

Dongguang Fan

Bin Wang

Giovanni Stelitano

Karin Savková

Olga Riabova

...

2023/7/12

Mycobacterium abscessus siderophores biosynthesis as a target to inhibit the iron uptake mechanism

Mario Cocorullo

Giovanni Stelitano

Matteo Mori

Giulia Cazzaniga

Martina Roversi

...

2023

Improving protection to prevent bacterial infections: preliminary applications of reverse vaccinology against the main cystic fibrosis pathogens

Mario Cocorullo

Laurent R Chiarelli

Giovanni Stelitano

2023/7/9

Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria

M Mori

A Tresoldi

G Cazzaniga

A Gelain

G Stelitano

...

2023/11/14

From virulence factors to drug development: MbtI as an effective Mycobacterium tuberculosis target

Giovanni Stelitano

Mario Cocorullo

Giulia Cazzaniga

Matteo Mori

Stefania Villa

...

2023

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis

ACS omega

Giulia Degiacomi

Beatrice Gianibbi

Deborah Recchia

Giovanni Stelitano

Giuseppina Ivana Truglio

...

2023/7/3

Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery

Pharmaceuticals

Matteo Mori

Stefania Villa

Laurent R Chiarelli

Fiorella Meneghetti

Marco Bellinzoni

2023/11/3

Synthesis, crystal structure, Hirshfeld surface, computational and antibacterial studies of a 9-phenanthrenecarboxaldehyde-based thiodihydropyrimidine derivative

Journal of Molecular Structure

Alakbar Huseynzada

Matteo Mori

Fiorella Meneghetti

Aygun Israyilova

Gamze Tuzun

...

2022/11/5

Crystal Structure, Hirshfeld Surface Analysis, In-Silico and Antimycotic Investigations of Methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1, 2-dihydropyrimidine-5-carboxylate

Crystals

Alakbar Huseynzada

Matteo Mori

Fiorella Meneghetti

Aygun Israyilova

Elif Guney

...

2022/12/27

WS01. 04 A new weapon against Mycobacterium abscessus

Journal of Cystic Fibrosis

G Degiacomi

LR Chiarelli

L Muñoz-Muñoz

D Recchia

G Stelitano

...

2022/6/1

Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity

G Cazzaniga

M Mori

F Meneghetti

LR Chiarelli

G Stelitano

...

2022/10/24

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis

Msphere

Elena G Salina

Umberto Postiglione

Laurent R Chiarelli

Deborah Recchia

Monika Záhorszká

...

2022/12/21

Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent

European Journal of Medicinal Chemistry

Giulia Cazzaniga

Matteo Mori

Fiorella Meneghetti

Laurent R Chiarelli

Giovanni Stelitano

...

2022/4/15

See List of Professors in Laurent Chiarelli University(Università degli Studi di Pavia)

Co-Authors

H-index: 129
Stewart Cole

Stewart Cole

École Polytechnique Fédérale de Lausanne

H-index: 82
Andrea Mattevi

Andrea Mattevi

Università degli Studi di Pavia

H-index: 40
Maria Rosalia Pasca

Maria Rosalia Pasca

Università degli Studi di Pavia

H-index: 32
Federico Forneris

Federico Forneris

Università degli Studi di Pavia

H-index: 28
Giovanna Valentini

Giovanna Valentini

Università degli Studi di Pavia

H-index: 20
Claudia Scotti

Claudia Scotti

Università degli Studi di Pavia

academic-engine